Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aleem Gangjee

Showing results (1-10 of 132) with videos related to

Pageof 14
Sort By:
Journal of Medicinal Chemistry|March 4, 2005
CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate reductaseAleem Gangjee, Xin Lin
Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Antifolates -- past, present and futureAleem Gangjee, Hiteshkumar D Jain
Bioorganic & Medicinal Chemistry|October 3, 2006
Novel non-classical C9-methyl-5-substituted-2,4-diaminopyrrolo[2,3-d]pyrimidines as potential inhibitors of dihydrofolate reductase and as anti-opportunistic agentsAleem Gangjee, Jie Yang, Sherry F Queener
Bioorganic & Medicinal Chemistry|January 29, 2013
Synthesis of 5,7-disubstituted-4-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amines as microtubule inhibitorsAleem Gangjee, Sonali Kurup, Charles D Smith
Journal of Medicinal Chemistry|June 25, 2004
Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitorsAleem Gangjee, Xin Lin, Sherry F Queener
Cancer Chemotherapy and Pharmacology|November 12, 2017
The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancerLarry H Matherly, Zhanjun Hou, Aleem Gangjee
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Novel 2-amino-4-oxo-5-arylthio-substituted-pyrrolo[2,3-d]pyrimidines as nonclassical antifolate inhibitors of thymidylate synthaseAleem Gangjee, Hiteshkumar D Jain, Roy L Kisliuk
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 21, 2022
The evolving biology of the proton-coupled folate transporter: New insights into regulation, structure, and mechanismZhanjun Hou, Aleem Gangjee, Larry H Matherly
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Recent advances in classical and non-classical antifolates as antitumor and antiopportunistic infection agents: part IAleem Gangjee, Hiteshkumar D Jain, Sonali Kurup
Anti-Cancer Agents in Medicinal Chemistry|February 22, 2008
Recent advances in classical and non-classical antifolates as antitumor and antiopportunistic infection agents: Part IIAleem Gangjee, Hiteshkumar D Jain, Sonali Kurup
Pageof 14

Showing results (1-10 of 132) with videos related to

Sort By:
Pageof 14
Journal of Medicinal Chemistry|March 4, 2005
CoMFA and CoMSIA analyses of Pneumocystis carinii dihydrofolate reductase, Toxoplasma gondii dihydrofolate reductase, and rat liver dihydrofolate reductaseAleem Gangjee, Xin Lin
Current Medicinal Chemistry. Anti-Cancer Agents|September 24, 2004
Antifolates -- past, present and futureAleem Gangjee, Hiteshkumar D Jain
Bioorganic & Medicinal Chemistry|October 3, 2006
Novel non-classical C9-methyl-5-substituted-2,4-diaminopyrrolo[2,3-d]pyrimidines as potential inhibitors of dihydrofolate reductase and as anti-opportunistic agentsAleem Gangjee, Jie Yang, Sherry F Queener
Bioorganic & Medicinal Chemistry|January 29, 2013
Synthesis of 5,7-disubstituted-4-methyl-7H-pyrrolo[2,3-d]pyrimidin-2-amines as microtubule inhibitorsAleem Gangjee, Sonali Kurup, Charles D Smith
Journal of Medicinal Chemistry|June 25, 2004
Design, synthesis, and biological evaluation of 2,4-diamino-5-methyl-6-substituted-pyrrolo[2,3-d]pyrimidines as dihydrofolate reductase inhibitorsAleem Gangjee, Xin Lin, Sherry F Queener
Cancer Chemotherapy and Pharmacology|November 12, 2017
The promise and challenges of exploiting the proton-coupled folate transporter for selective therapeutic targeting of cancerLarry H Matherly, Zhanjun Hou, Aleem Gangjee
Bioorganic & Medicinal Chemistry Letters|April 20, 2005
Novel 2-amino-4-oxo-5-arylthio-substituted-pyrrolo[2,3-d]pyrimidines as nonclassical antifolate inhibitors of thymidylate synthaseAleem Gangjee, Hiteshkumar D Jain, Roy L Kisliuk
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 21, 2022
The evolving biology of the proton-coupled folate transporter: New insights into regulation, structure, and mechanismZhanjun Hou, Aleem Gangjee, Larry H Matherly
Anti-Cancer Agents in Medicinal Chemistry|September 28, 2007
Recent advances in classical and non-classical antifolates as antitumor and antiopportunistic infection agents: part IAleem Gangjee, Hiteshkumar D Jain, Sonali Kurup
Anti-Cancer Agents in Medicinal Chemistry|February 22, 2008
Recent advances in classical and non-classical antifolates as antitumor and antiopportunistic infection agents: Part IIAleem Gangjee, Hiteshkumar D Jain, Sonali Kurup
Pageof 14